Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jeffrey Faint"'
Autor:
Neil T. Raymond, Stephen Harding, Jeffrey Faint, Srikanth Bellary, Lakhvir K. Assi, Colin A. Hutchison, Anthony H. Barnett
Publikováno v:
Diabetes care. 37(7)
OBJECTIVE Elevated polyclonal serum immunoglobulin free light chains (FLCs; combined FLCκ+FLCλ [cFLC]) are associated with adverse clinical outcomes and increased mortality; we investigated cFLC and cardiovascular disease (CVD) events in type 2 dia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f6da115666b54ee8a129462561868b4
https://pubmed.ncbi.nlm.nih.gov/24742658
https://pubmed.ncbi.nlm.nih.gov/24742658
Autor:
Colette E. Jackson, Stephen Harding, Lakhvir K. Assi, Jeffrey Faint, Bridget Gunson, Supratik Basu, Adeel Mushtaq, David Sutton, Paul Cockwell, Hugh D. Carr-Smith, Paul J. Showell, Philip A. Kalra
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM).
Background: Elevated polyclonal serum free light chain (FLC) levels have been associated with increased mortality and disease activity in many conditions. Currently, polyclonal FLC quantification requires summation of individual FLCκ and FLCλ assay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::209afafb02b2e78eac212275df61ae79
https://doi.org/10.1515/cclm-2014-0279
https://doi.org/10.1515/cclm-2014-0279
Autor:
Patricia F. Lalor, Samuel Hadley, Evaggelia Liaskou, Jeffrey Faint, Janine Youster, Sumera Karim, David H. Adams
Alcoholic liver disease (ALD) is one of the commonest causes of cirrhosis and liver failure in the developed world. Hepatic inflammation is the critical stage in progression of both ALD and non-ALD, but it remains difficult to study the underlying me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3180b63694f1cdfc8685510f56966829
https://europepmc.org/articles/PMC3576009/
https://europepmc.org/articles/PMC3576009/
Autor:
Tadashi Isomura, Stephen Harding, Miho Shimada, Masanori Hirota, Taiko Horii, Akira Matsumori, Jeffrey Faint, Hisayoshi Suma, Joji Hoshino, Toshio Shimada
Publikováno v:
Global Heart. 10:e6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::030d33f1599d67859cd27275f644c813
https://doi.org/10.1016/j.gheart.2015.03.023
https://doi.org/10.1016/j.gheart.2015.03.023
Autor:
Stephen Harding, Supratik Basu, Sunil Honda, David Sutton, Jeffrey Faint, Ladan Mirbahai, Abe Jacob, Alan Macwhannell, Anandram Seetharam
Publikováno v:
Blood. 120:4001-4001
Abstract 4001 Introduction Serum free light chain (FLC) measurements are used routinely to identify monoclonal immunoglobulin (M-Ig) production in patients. In addition, summated kappa + lambda concentrations have recently been shown to have prognost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b9f484da66f70e5a4de5c082a8b4625
https://doi.org/10.1182/blood.v120.21.4001.4001
https://doi.org/10.1182/blood.v120.21.4001.4001
Autor:
Stephen Harding, Wolfgang Hübl, Arthur R. Bradwell, Philip J. Young, Heinz Ludwig, Niklas Zojer, Dejan Milosavljevic, Jeffrey Faint
Publikováno v:
Blood. 118:2883-2883
Abstract 2883 In MM, increasing evidence indicates progressive clonal evolution A novel polyclonal immunoassay specific for the different light chain types of intact immunoglobulins (Ig) (heavy/light chain assays; HLC) and the serum free light chain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0699562620143652192f43dcda00ab50
https://doi.org/10.1182/blood.v118.21.2883.2883
https://doi.org/10.1182/blood.v118.21.2883.2883
Autor:
Guy Pratt, Stephen Harding, Jeffrey Faint, Chris Pepper, Anne Gardiner, Christopher Fegan, David Oscier, Alison Levoguer
Publikováno v:
Blood. 116:4608-4608
Abstract 4608 Introduction Serum free light chain (sFLC) ratios have prognostic value in many haematological malignancies, including multiple myeloma (Kyrtsonis 2007), Waldenstrom's macroglobulinaemia (Leleu, 2007), solitary plasmacytoma of bone (Din
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7e46875b7213ce30350294792619a70
https://doi.org/10.1182/blood.v116.21.4608.4608
https://doi.org/10.1182/blood.v116.21.4608.4608
Publikováno v:
British Journal of Cancer. 4/29/2014, Vol. 110 Issue 9, p2277-2282. 6p.